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Improvements in the technology of cardiopulmonary bypass (CPB) have sig-nificantly reduced morbidity after repair of complex congenital heartdefects, even in very small neonates. Use of CPB, however, may exposeinfants to extremes of hemodilution and hypothermia, often in associationwith tissue ischemia, as well as initiate a systemic inflammatory responsewith significant accumulation of excess body water. Organ dysfunction
after CPB, especially the heart, lungs, and brain, may result in significant postoper-
ative morbidity and mortality. A variety of techniques have been developed to
reverse the increase in total body water (TBW) after CPB, including ultrafiltration
during CPB, postoperative peritoneal dialysis, postoperative continuous arteriove-
nous hemofiltration, and aggressive use of diuretics postoperatively. Ultrafiltration
is a technique that removes plasma water and low molecular weight solutes by a
convective process using hydrostatic forces across a semipermeable membrane. The
composition of the ultrafiltrate is dependent on the pore size of the hemofilter.
Ultrafiltration was initially used during CPB, usually during rewarming (conven-
tional ultrafiltration or CUF). The volume of filtrate that can be removed during
CUF is restricted by the volume of the venous reservoir, and thus CUF provides
only a limited ability to remove excess water and reverse hemodilution. 
Because of dissatisfaction with the ability of CUF to consistently prevent the
increase in TBW and reverse hemodilution after CPB in infants, Naik, Knight and
Elliott1,2 introduced a technique of ultrafiltration after separation from CPB, which
they termed modified ultrafiltration (MUF). In a preliminary study, they compared
the efficacy of no ultrafiltration, CUF, and MUF in preventing accumulation of
excess TBW.1 Changes in TBW were monitored by bioelectric impedance. The vol-
ume of filtrate that could be removed during MUF was significantly greater than
during CUF. MUF significantly reduced the postoperative increase in TBW, where-
as results with CUF were no different from control. CUF did prevent the increase
in TBW in some patients; however, the response was neither uniform nor repro-
ducible. In a prospective randomized trial, MUF was shown to significantly reduce
the accumulation of TBW, decrease postoperative blood loss, and decrease postop-
erative blood product use when compared with no ultrafiltration.2 Unexpectedly,
MUF resulted in a significant increase in arterial blood pressure. In a subsequent
study, MUF was shown to increase cardiac index and decrease pulmonary vascular
resistance with unchanged systemic vascular resistance. The hemodynamic benefits
of MUF correlated directly with increasing hematocrit value and thus the degree of
hemoconcentration.3
Since publication of these initial studies, there has been increasing interest in the
use of ultrafiltration both during and after CPB. A MEDLINE keyword search iden-
tified 40 articles discussing MUF since 1995. Use of MUF has been shown to
decrease TBW accumulation, postoperative blood loss, and blood product use;
improve left ventricular systolic function, improve alveolar-arterial oxygen gradient
and lung compliance; decrease the frequency of pulmonary hypertensive episodes;
decrease the duration of postoperative ventilation; and decrease the incidence of
pleural effusions after cavopulmonary connection and the Fontan procedure.1-7
Despite these reports of beneficial efforts, there has been increasing confusion and
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controversy concerning use of MUF. Much of this contro-
versy stems from the lack of a standard definition or method
for MUF. In the initial report, MUF was performed in an
arteriovenous fashion.1,2 After separation from CPB, blood
is withdrawn from the aortic cannula and is passed through
the hemofilter, and the concentrated blood is returned to the
right atrium. As fluid is removed from the patient, the filling
pressures decrease. Blood from the bypass circuit is con-
centrated with the filter and infused to maintain intravascu-
lar volume. MUF thus provides the capability to remove
excess water from the patient and salvage blood from the
bypass circuit. MUF is continued until the hematocrit value
is 40% or no blood remains in the bypass circuit. Some stud-
ies have used venovenous MUF, in which blood is with-
drawn from the right atrium and returned to the right atrium.
No direct comparisons of the effectiveness of arteriovenous
MUF and venovenous MUF have been performed. Journois
and colleagues8 reported a modification of CUF, which they
termed zero-balance ultrafiltration, in which ultrafiltration is
performed during rewarming and the filtrate is replaced by
crystalloid solution to maintain reservoir volume while
allowing continuous hemofiltration. After separation from
CPB, MUF is performed to reverse hemodilution. A similar
technique has been termed dilutional ultrafiltration.6 In
addition to differences in technique, there has been signifi-
cant variability in the criteria chosen for termination of
MUF. A survey of 22 institutes revealed that 10 continued
MUF until the circuit contents were completely salvaged, 5
used a time-based criterion, 1 used a hematocrit end point,
1 used a filtrate-volume end point, and 5 used other end
points.9 The use of varying techniques and end point crite-
ria has made interpretation of published results difficult;
nonetheless, the beneficial effects of MUF have been inde-
pendently reproduced at many institutions.
Concerns have been raised about potential risks and com-
plications of MUF.10,11 There was initial concern that MUF
would lead to hemodynamic instability by withdrawing
blood from the arterial cannula immediately after separation
from CPB. Actually, the converse proved true and MUF
results in an increase in arterial blood pressure with
decreased filling pressures and improved cardiac perfor-
mance. Multiple studies have demonstrated that concerns
over possible complications are primarily theoretical. In
their review of MUF at 22 centers, Darling and associates9
found no reports of MUF-related morbidity or mortality.
The mechanisms by which MUF produces beneficial
effects have not been fully elucidated. Potential mechanisms
include reduction of tissue edema, hemoconcentration, and
removal of inflammatory mediators. Initially, MUF was
hypothesized to improve organ function by simply reducing
excess TBW and tissue edema.1,2 Studies of the ultrafiltrate,
however, demonstrated substantial amounts of inflammato-
ry mediators and vasoactive substances, including inter-
leukins 6, 8, and 10, tumor necrosis factor α, and endothe-
lin-1.6,8,11,12 One rationale for use of CUF and zero-balance
ultrafiltration is to initiate removal of mediators early in the
inflammatory cascade and thus decrease the severity of the
inflammatory response.6,8 Although it is tempting to specu-
late that removal of these mediators diminishes the inflam-
matory response to CPB, thus ameliorating some of the
adverse sequelae, no study has yet established a definite
relationship between removal of inflammatory mediators
and improved outcome. The positive benefits of MUF, how-
ever, do correlate with the volume of filtrate removed. In a
carefully designed study, Daggett and associates13 evaluat-
ed the effectiveness of no ultrafiltration, CUF, and MUF in
preventing tissue edema and organ dysfunction using a
neonatal swine model of CPB. MUF was more effective in
preventing accumulation of TBW and myocardial edema.
MUF also resulted in a significant improvement in left ven-
tricular contractility, assessed by the preload recruitable
stroke work index. Interestingly, reinfusion of the filtrate
resulted in depressed myocardial function, suggesting the
filtrate does contain potentially toxic factors. In a clinical
study evaluating the effect of MUF on left ventricular sys-
tolic function using load-independent measures of myocar-
dial performance, changes in left ventricular systolic func-
tion were shown to correlate positively with the degree of
hemoconcentration. The concentration of inflammatory
mediators in the filtrate does not differ between CUF and
MUF. However, because the volume of filtrate removed is
significantly greater with MUF, removal of mediators is cor-
respondingly greater.12 Thus, whether the mechanism is
reduction in TBW or removal of inflammatory mediators,
MUF is more effective then CUF because a greater volume
of filtrate can be removed.
In this issue of the Journal, Thompson and colleagues14
report results of a study comparing outcomes after CUF and
MUF when a standardized volume of fluid is removed. The
stated goal of the study was to determine whether “MUF has
any intrinsic benefit over CUF aside from the potentially
greater volume of fluid removed. . . .” The volume of filtrate
removed was arbitrarily set at 50% to 60% of the “effective
fluid balance,” defined as the priming volume plus volume
added during CPB, less the urine output. Despite the stan-
dardization of CPB, CUF patients received a significantly
larger priming volume and a larger volume was added dur-
ing CPB, even though the MUF patients were larger. The
reasons for the increased priming volume are unclear; how-
ever, it is likely that more volume was added during CPB to
maintain the reservoir level during CUF. Because of this
additional volume, a significantly greater volume of filtrate
was removed during CUF than during MUF (96 vs 69
mL/kg; P = .01). There was no difference in outcome
between the 2 groups. The study design suggests a misun-
derstanding of the rationale for MUF. MUF was introduced
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to allow safe removal of a greater volume of fluid than pos-
sible during CUF and thus more effectively prevent accu-
mulation of TBW, not because any special efficacy of ultra-
filtration performed after separation from CPB. The
composition of the filtrate remains the same whether ultra-
filtration is performed during rewarming or a few minutes
later after separation from CPB. Indeed, one of the authors
of this study stated in a recent editorial that “modified ultra-
filtration filters the CPB perfusate in exactly the same way
as conventional ultrafiltration, except the filtration process
is performed after separation from cardiopulmonary
bypass.”10 The beneficial effects of MUF compared with
CUF are dependent on more aggressive fluid removal.
Therefore, a study design that limits the filtrate volume dur-
ing MUF predetermines the result. Unfortunately, this study
adds little useful information to the ongoing debate con-
cerning the optimal use of ultrafiltration during and after
CPB.
At The Children’s Hospital of Philadelphia, both CUF
and MUF are used in neonates and infants during and after
CPB, including those undergoing staged reconstruction for
hypoplastic left heart syndrome. In an 18-month period,
MUF was performed in 467 patients weighing less than 15
kg. The median age was 4 months and the median weight
was 5 kg. CUF was used in 87% of these patients. MUF is
continued until the circuit contents have been completely
salvaged. The mean volume of ultrafiltrate removed was
129 ± 60 mL/kg. The filtrate volume was greater than 100
mL/kg in 65% of patients and greater than 150 mL/kg in
30%. The baseline hematocrit value was 38% ± 7% and
decreased to 25% ± 4% at the end of CPB. MUF resulted in
an increase to 40% ± 6%. The mean duration of MUF was
12 ± 3 minutes. There were no MUF-related complications.
Multiple studies have demonstrated that ultrafiltration,
both during and after CPB in children, is safe and reduces
postoperative morbidity, yet many important questions
remain unresolved. It is important to recognize that CUF
and MUF are not competing, mutually exclusive techniques
but rather are complementary techniques with potentially
additive positive effects. Filtration during CPB (CUF or
zero-balance ultrafiltration) may be used to remove inflam-
matory mediators and vasoactive substances, whereas MUF
is performed after CPB to reverse hemodilution and
decrease tissue edema. The optimal use of ultrafiltration in
children undergoing repair of congenital heart defects will
likely result from a combined technique. The mechanisms
by which ultrafiltration results in improved organ function
require additional investigation. As the technology and prac-
tice of CPB change with decreased use of hemodilution,
introduction of smaller circuits, and less use of hypothermia
and circulatory arrest, the indications for ultrafiltration are
likely to change as well. Further studies are necessary to
identify the patients most likely to benefit from ultrafiltra-
tion and to define the best protocols for the use of ultrafil-
tration in these patients.
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